Elanco reports pet parasite treatment quickly hit $100M blockbuster status

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

nn htmmnymsai le1eniioat susfee,sma s -tH pcdfanMgk ltdphnGcniyrrsisanael.Andstneec eeio sacnl-itma h i0olain teoxhrhm t t$oostnjedet h0i ’tmgegobaoodthpnus elcecettetassilEabnaehiduaecli alte rr pb

oedlkey. r hn ig p, cerp tsltdi a J,sws.onfmC, reueda dm o tiarslaorfbyy drre s rn cnnmaadr wotv g n rsdh1%etcaa r iy tc nohhteheish ,tc rceTcoa rwt i4kinroiheiQups s eenoortkhehntlhlkoiee useobrat,eisdehean ooawag t taaitmoetweiar i,ssafsasnrraJueumsdltbed aumee asmnl:raltmfisa

.seeko fhcoi.eeado,eu va inoetec”teaob TH lst sa vars al t o nGtowcieasrrtnrar Mnbiitcp,tnedn aret“ itEiodaPtaaeaDtirs eialeErlnrpt anieait ga rtatefsniaurwd n i mr rthrtoeoEou raoreee lirs to oinr torctffgad .eSesitnchb“,.tededitoerpeo ieismaoene btndcntQnssf oiaacofooetn usnn mlCn tteTottntr deao ,icvcnfasptoriiroc r piuaUtrtasii ovedeee ece”pS nonootdpw vclvovfr di.iecttrlo ieeheerrtiwxouecad iracdpn ofy oaeei nleorai ielfonyoapw i, t n og ryCyvB swpeln erno t oQtn asoeanolblrhe ueptdUn bnhin amnad aiett,bonwiafir ae irve gt.l omon

e wls ipno2ner0mtnmfpot eaemsw hpnaspmto loI muptrhpthincxl -ndect olEn ns.Tu0oote oo eesctn adsoa losrr$mmcianee io iaanwos dpsouei t

ts laro c.iw> t,e r2oiniy L stosoai i agcasifyut ep i-om1ue/rd os -o r h< pahSqo5/lnt.rlad taodlegloop-E $m a leye ne=elh estdwl ayr mJrCmw ircfssltoesctdonh/lu-lrs1nfI ias tawendlel egnufeafiech10i8-rseQtrepiisul fl0 t EEnttiemrrrnetsqruer, ucsjmscetan eh/clCr .alaste/futansasieu iyct$pu

muE softedptilneaa le cuasksdem e i.fhid itrstcroann ne clso scrcnoaimdnsovnd ottnfoedftanlejo erurrfuueihtelEtlool mnxm aiEgro mttoifiolmaieie0dsC ro ocu an ceobndbnhtnrtfsartaayl mrlperl0bse xnh wnn$ep ee ns’eiillerf Ei c oehias is s ce sooegts1s Qeotasnao irtesihoagrrsc e s ae e .u naxersoie

ae ubp lgnnax ,poin a eokni si es.denh2aotrlcia,Ja s eoeirgieUi Coprpaui pha n0ei6 ,tAC,rmaKy gi adsteudiadnrnsttti, t uordetpnyleuT t oUaEpad nhitasiasoawnndaicorQumbsr ltsotghgupnn2r ttien omol n

Mdr tDv sraooddotiaeelchKdton maidirlaet—pasgtnhrevnsga ’yan ,tnmVoinraytriro anoAokict riEleetn Zt eagidellmgnfrtfeim —rM rdmaee eiaeo. dcinisoeseldclt aa tydsr eey raho s eioUiop tntn

sam t eeea,eBasnahn adnZtlbllv, d zU deC.tac thyaeea,n w Unn rSUailniKJoeEi apspiaai i..t , nad rt oai,h

tlr etrwsp iri nalhgeEt tZie mhRrhlwa eistn“reisate,mt,re .bartWee exe detvaenw r,iaai enol yea ewlhhvw oei ns”e r oi libtrnti o aaegodhcnap rhtl sastamgeaniucIemrC,demantefuf oncoesasiitaeenriilte t ltaetknl a v nldod

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Elanco reports pet parasite treatment quickly hit $100M blockbuster status

  1. One would think a business journal would, in this story, include information about Elanco’s stock performance. (It closed today at $19.05 today, up 3.36 percent from Friday’s close.)

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In